Total Payments
$50,389
2024 Payments
$299.71
Companies
14
Transactions
146
Medicare Patients
734
Medicare Billing
$46,618
Payment Breakdown by Category
Other$40,495 (80.4%)
Travel$6,982 (13.9%)
Food & Beverage$2,911 (5.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $40,495 | 23 | 80.4% |
| Travel and Lodging | $6,982 | 16 | 13.9% |
| Food and Beverage | $2,911 | 107 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $49,350 | 103 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $293.79 | 6 | $0 (2020) |
| AbbVie Inc. | $222.07 | 14 | $0 (2020) |
| Veloxis Pharmaceuticals, Inc. | $152.27 | 6 | $0 (2024) |
| Incyte Corporation | $92.91 | 1 | $0 (2019) |
| Ipsen Biopharmaceuticals, Inc | $82.14 | 4 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $46.11 | 3 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $42.55 | 3 | $0 (2019) |
| GENZYME CORPORATION | $33.95 | 1 | $0 (2019) |
| EISAI INC. | $18.57 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $299.71 | 18 | Gilead Sciences, Inc. ($130.66) |
| 2021 | $405.00 | 1 | Gilead Sciences, Inc. ($405.00) |
| 2020 | $7,972 | 15 | Gilead Sciences, Inc. ($7,915) |
| 2019 | $15,390 | 47 | Gilead Sciences, Inc. ($14,981) |
| 2018 | $11,779 | 32 | Gilead Sciences, Inc. ($11,680) |
| 2017 | $14,543 | 33 | Gilead Sciences Inc ($14,238) |
All Payment Transactions
146 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: CRITICAL CARE | ||||||
| 09/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.51 | General |
| 09/06/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: TRANSPLANTATION | ||||||
| 09/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.34 | General |
| 08/23/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Rare Disease | ||||||
| 08/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.02 | General |
| 08/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $0.51 | General |
| 08/09/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Rare Disease | ||||||
| 07/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.20 | General |
| 06/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.61 | General |
| 06/14/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Rare Disease | ||||||
| 06/07/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: TRANSPLANTATION | ||||||
| 05/18/2024 | Ipsen Biopharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 05/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.20 | General |
| 05/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Gastroenterology | ||||||
| 04/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.06 | General |
| 02/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.99 | General |
| 01/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.22 | General |
| 10/18/2021 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $405.00 | General |
| Category: HCV | ||||||
| 12/14/2020 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: HCV | ||||||
| 10/06/2020 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,520.00 | General |
| Category: HCV | ||||||
| 08/14/2020 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: HCV | ||||||
| 03/24/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: VIROLOGY | ||||||
| 03/14/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $8.34 | General |
| 03/07/2020 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $786.60 | General |
| Category: HCV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 181 | 204 | $61,866 | $11,604 |
| 2022 | 3 | 126 | 138 | $24,248 | $7,278 |
| 2021 | 2 | 224 | 299 | $53,602 | $16,282 |
| 2020 | 2 | 203 | 274 | $44,275 | $11,453 |
Total Patients
734
Total Services
915
Medicare Billing
$46,618
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 88 | 95 | $36,708 | $6,723 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 78 | 82 | $21,361 | $3,909 | 18.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 27 | $3,797 | $972.40 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 91 | 103 | $16,480 | $4,884 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 22 | 22 | $6,468 | $2,078 | 32.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 13 | 13 | $1,300 | $316.91 | 24.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 181 | 256 | $40,960 | $11,845 | 28.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 43 | 43 | $12,642 | $4,437 | 35.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 167 | 238 | $32,965 | $7,974 | 24.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 36 | 36 | $11,310 | $3,479 | 30.8% |
About Dr. Harlan Wright, MD
Dr. Harlan Wright, MD is a Hepatology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386653590.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harlan Wright, MD has received a total of $50,389 in payments from pharmaceutical and medical device companies, with $299.71 received in 2024. These payments were reported across 146 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($40,495).
As a Medicare-enrolled provider, Wright has provided services to 734 Medicare beneficiaries, totaling 915 services with total Medicare billing of $46,618. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Hepatology
- Location Oklahoma City, OK
- Active Since 08/05/2006
- Last Updated 11/15/2021
- Taxonomy Code 207RI0008X
- Entity Type Individual
- NPI Number 1386653590
Products in Payments
- Epclusa (Drug) $37,060
- Vosevi (Drug) $4,415
- OCA (Drug) $229.04
- Mavyret (Drug) $155.43
- OCALIVA (Drug) $64.75
- IQIRVO (Drug) $62.14
- ENVARSUS (Drug) $52.92
- Envarsus (Drug) $49.17
- MAVYRET (Drug) $44.17
- THYMOGLOBULIN (Drug) $33.95
- XIFAXAN (Drug) $31.94
- Envarsus XR (Drug) $26.09
- Envarsus XR (SP) (Drug) $24.09
- Viekira (Drug) $22.47
- Lenvima (Drug) $18.57
- TERLIVAZ (Drug) $14.73
- Kanuma (Drug) $14.58
- MOVIPREP (Drug) $14.43
- PLENVU (Drug) $14.17
- Doptelet (Drug) $13.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hepatology Doctors in Oklahoma City
Joykumar Patel, M.d, M.D
Hepatology — Payments: $452,780
Hepatology $452,780
Dr. Hamid Sima, M.d, M.D
Hepatology — Payments: $1,873
Hepatology $1,873
Dr. Jason Cheng, M.d, M.D
Hepatology — Payments: $1,260
Hepatology $1,260
Elias Spyrou, M.d., Phd, M.D., PHD
Hepatology — Payments: $438.93
Hepatology $438.93